Prospective postmarketing surveillance of acute myocardial infarction in new users of saxagliptin: A population-based study
Diabetes Care Nov 15, 2017
Toh S, et al. - This population-based study was performed to prospectively investigate the relationship between saxagliptin use and acute myocardial infarction (AMI). During the first 5 years after U.S. Food and Drug Administration approval of the drug, the researchers did not find a higher AMI risk in saxagliptin users compared with users of other selected antihyperglycemic agents.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
